←
Azad Bonni224 posts
Azad Bonni avatar

Azad Bonni

@AzadBonni

SVP Global Head of Neurology Product Development, Roche-Genentech

◷ Joined October 2018▧ 15 Photos and videos
Azad Bonni avatar
Azad Bonni@AzadBonni·27 Sep 2025

In case you missed it: I am proud to share one of our studies from the summer, in which we report a conceptual advance in the science and medicine of ubiquitin signaling in genetic neurodevelopmental disorders! nature.com/articles/s41591-0…

Azad Bonni avatar
Azad Bonni@AzadBonni·11 Mar 2025

Delighted to announce @LukaKulic90270 has been appointed VP & Head of Early Development in Neuroscience & Rare Diseases at @Roche pRED! Luka brings expertise and proven track record to advance our early clinical pipeline toward medicines for patients with neurological disorders!

Azad Bonni avatar
Azad Bonni@AzadBonni·24 Jan 2025

Congratulations @HaoChen_neuro, @cjfMDPhD, and @AlbertHKimMDPhD as well as collaborators for an exciting study and identification of a novel ubiquitin signaling link in the brain with implications for understanding genetic neurodevelopmental disorders!

Congrats to @HaoChen_neuro and the team on his paper on Hao-Fountain syndrome. A fantastic collaboration with @AzadBonni and Cole Ferguson. @WashUNeurosurg cell.com/cell-reports/fullte…

Post attachment
Azad Bonni avatar
Azad Bonni@AzadBonni·12 Aug 2024

Congratulations @dngman and colleagues on your publication! This area of research is critical to our ability to develop novel biomarkers for the study of brain disorders. Keep up the great work!

To preprocess or not to preprocess your #EEG 🔮when using #ML? 💫An enhanced version of our latest work at @Roche is now published in @eBioMedicine thelancet.com/journals/ebiom… #DeepDive #Thread 🧵in next post 👉👉🏾👉🏻

Post attachment
Azad Bonni avatar
Azad Bonni@AzadBonni·18 Jun 2024

Excited about the partnership with @AscidianTx, which aligns with @Roche pRED's gene therapy strategy in neuroscience! The collaboration promises to advance treatments for patients with devastating neurological disorders. #Neuroscience #RewritingRNA #RNAExonEditing #genetherapy

It’s an exciting day at Ascidian as we announce a collaboration with @Roche. We’re thrilled to combine our #RNA #ExonEditors with the next generation #CNS delivery capabilities of Roche to tackle complex neurological diseases. Learn more👉tinyurl.com/55py8866

0:34
Azad Bonni avatar
Azad Bonni@AzadBonni·15 Apr 2024

Pleased to share our paper in @NatureMedicine presenting an exploratory analysis of a Phase 2 study in Parkinson's disease! It is a significant step forward toward developing a treatment that can effectively slow the progression of Parkinson's disease. nature.com/articles/s41591-0…

Roche@Roche15 Apr 2024

✨There is hope that Parkinson's will one day be eliminated. Recognition of the importance of certain protein formations has brought us to the brink of a revolution. The goal: personalise medicine for each patient. 🌈 Check it out: spkl.io/60174FWl3

Post attachment
Azad Bonni avatar
Azad Bonni@AzadBonni·7 Jan 2024

Interested candidates with strong background in any area of biology should send a cover letter and CV by email to fabienne.dietler@roche.com, c/o Azad Bonni, MD, PhD, Senior Vice President and Global Head of Neuroscience and Rare Diseases, Roche pRED. 5/5

Azad Bonni avatar
Azad Bonni@AzadBonni·7 Jan 2024

that orchestrate neuronal connectivity in the brain. For background information, see the following papers (Yang et al. Science 2016; Yamada et al. Nature 2019; Chen et al. Nature 2022; Ferguson et al. Mol Cell 2022). 4/5

Azad Bonni avatar
Azad Bonni@AzadBonni·7 Jan 2024

We employ diverse tools from human iPSC-induced cells and mouse genetics to single cell transcriptomics and proteomics to genome architecture and epigenomics to morphology and electrophysiology to define the epigenetic, transcriptional, and ubiquitin signaling networks 3/5

Azad Bonni avatar
Azad Bonni@AzadBonni·7 Jan 2024

The chief goal of the Bonni laboratory is to identify the key principles and mechanisms that govern the assembly and function of neural circuits in the brain and to determine how deregulation of these fundamental mechanisms contributes to neurological disorders. 2/5

Azad Bonni avatar
Azad Bonni@AzadBonni·7 Jan 2024

Interested in postdoctoral training in fundamental neurobiology in an environment of a world-leading R&D unit, apply to have the best of both worlds! Please RT 1/5

Azad Bonni avatar
Azad Bonni@AzadBonni·10 Oct 2023

So humbled and grateful to @WUSTLneurosci for this incredible honor!! Super excited and looking forward to share a wonderful day of science with colleagues and friends from around the world at Washington University in St. Louis @WUSTL!!

Please mark your calendars for a very special event in January: the Azad Bonni Symposium, honoring the contributions of @AzadBonni as Chair of the Department of Neuroscience. Find details & register here: neuroscience.wustl.edu/regis…

Azad Bonni avatar
Azad Bonni@AzadBonni·28 Sep 2023

We are very excited to collaborate with @ionispharma , continuing our deep commitment to finding treatments for #Alzheimer's and #Huntington's diseases! Thanks to the many colleagues who made this partnership possible!

Roche@Roche27 Sep 2023

Today, we announced a new collaboration with Ionis to develop two novel treatments for Alzheimer’s and Huntington’s disease. Teaming up with Ionis is a testimony to the strength of this partnership and the benefits both companies see in working together. spkl.io/60154mwTW

Post attachment
Azad Bonni avatar
Azad Bonni@AzadBonni·3 Jul 2023

This is a fantastic opportunity at the intersection of academia and industry, where you can have the best of both worlds in the vibrant city of Basel!

We’re seeking Early Career Scientists to establish their own independent #research program, with competitive funding, across three key focal areas. Open to mature #scientists with PhD or Postdoctoral training in #HumanModelSystems. Apply to #TeamIHB here: bit.ly/3NyRjul

Post attachment